Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cardiovascular Diseases D002318 24 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Cholecystitis D002764 8 associated lipids
Cholestasis D002779 23 associated lipids
Cholestasis, Intrahepatic D002780 4 associated lipids
Chromoblastomycosis D002862 2 associated lipids
Cluster Headache D003027 4 associated lipids
Colitis D003092 69 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Colonic Diseases D003108 5 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Conjunctivitis D003231 7 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Contracture D003286 3 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Terashita Z et al. Protective effects of a platelet activating factor (PAF) antagonist and its combined treatment with prostaglandin (PG) E1 in traumatic shock. 1988 J. Cardiovasc. Pharmacol. pmid:2468048
Elstad MR et al. Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes. 1988 J. Immunol. pmid:3126231
Dulioust A et al. Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4+ cell proliferation. 1988 J. Immunol. pmid:2961808
Winkler JD et al. Leukotriene B4-induced homologous desensitization of calcium mobilization and phosphoinositide metabolism in U-937 cells. 1988 J. Pharmacol. Exp. Ther. pmid:2839662
Croft KD et al. Effect of dietary fish oils on the formation of leukotriene B4 and B5, thromboxane and platelet activating factor by rat leukocytes. 1988 Clin. Exp. Pharmacol. Physiol. pmid:2856061
Bahr T et al. Influence of inhibitors of the eicosanoid metabolism, of antagonists of the eicosanoids and of PAF on mortality assayed in three biochemically characterized shock models. 1988 Biomed. Biochim. Acta pmid:3150272
Powling MJ and Hardisty RM Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. 1988 Thromb. Haemost. pmid:3388294
Pirotzky E et al. Cyclosporine-induced nephrotoxicity: preventive effect of a PAF-acether antagonist, BN 52063. 1988 Transplant. Proc. pmid:3388505
Ward SG and Westwick J Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. 1988 Br. J. Pharmacol. pmid:3390650
Demopoulos CA et al. Abnormal platelet response to PAF and ADP in beta-thalassaemia. 1988 Int. J. Biochem. pmid:3391336
Christman BW et al. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. 1988 J. Appl. Physiol. pmid:3391901
Roberts NM et al. Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects. 1988 J. Allergy Clin. Immunol. pmid:3403863
Koenderman L et al. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. 1988 J. Leukoc. Biol. pmid:3404069
Anderson GP and Fennessy MR Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. 1988 Agents Actions Suppl. pmid:3140616
Bass DA et al. Selective priming of rate and duration of the respiratory burst of neutrophils by 1,2-diacyl and 1-O-alkyl-2-acyl diglycerides. Possible relation to effects on protein kinase C. 1988 J. Biol. Chem. pmid:3198643
Lewis MS et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. 1988 J. Clin. Invest. pmid:3198764
Page CP et al. Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. 1988 Agents Actions Suppl. pmid:3051932
Makino S [Platelet activating factor in allergic reaction]. 1988 Arerugi pmid:3052368
Misawa M and Takata T Effects of platelet-activating factor on rat airways. 1988 Jpn. J. Pharmacol. pmid:3199608
Wasserman SI Platelet-activating factor as a mediator of bronchial asthma. 1988 Hosp. Pract. (Off. Ed.) pmid:3053741
Cunha FQ et al. Failure of PAF-acether to induce in vivo neutrophil migration. 1988 Agents Actions pmid:3055873
Kato T et al. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). 1988 Biochem. Biophys. Res. Commun. pmid:3202869
Keery RJ and Lumley P AH6809, a prostaglandin DP-receptor blocking drug on human platelets. 1988 Br. J. Pharmacol. pmid:2460179
Foegh ML Eicosanoids and platelet activating factor mechanisms in organ rejection. 1988 Transplant. Proc. pmid:3059615
Roberts NM et al. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. 1988 Br J Clin Pharmacol pmid:3203062
Weisman SM et al. Differential effect of platelet-activating factor (PAF) receptor antagonists on peptide and PAF-stimulated prostaglandin release in unilateral ureteral obstruction. 1988 Biochem. Pharmacol. pmid:2840083
Lee TC et al. Formation of 1-alkyl-2-acetyl-sn-glycerols via the de novo biosynthetic pathway for platelet-activating factor. Characterization of 1-alkyl-2-acetyl-sn-glycero-3-phosphate phosphohydrolase in rat spleens. 1988 J. Biol. Chem. pmid:2828351
Nieto ML et al. Biosynthesis of platelet-activating factor in human polymorphonuclear leukocytes. Involvement of the cholinephosphotransferase pathway in response to the phorbol esters. 1988 J. Biol. Chem. pmid:2828363
Ponpipom MM et al. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. 1988 Biochem. Biophys. Res. Commun. pmid:2829894
O'Donnell SR and Barnett CJ pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets. 1988 Br. J. Pharmacol. pmid:3293683
Hwang SB Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. 1988 J. Biol. Chem. pmid:2830276
Giovannini L et al. N-acetyl-beta-glucosaminidase (NAG) and alpha-glycosidase released by PAF in isolated perfused rat kidney. 1988 Int J Tissue React pmid:3294206
Marquis O et al. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes. 1988 J. Pharmacol. Exp. Ther. pmid:2831350
Kramer RM et al. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. 1988 Biochim. Biophys. Acta pmid:3355850
McGowan HM et al. Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. 1988 Clin. Sci. pmid:3356112
Abraham WM and Wanner A Inflammatory mediators of asthma. 1988 Pediatr. Pulmonol. pmid:2455882
Quinn MT et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. 1988 Proc. Natl. Acad. Sci. U.S.A. pmid:3357891
Tatsumi N et al. Neutrophil chemiluminescence induced by platelet activating factor and suppressed by C-reactive protein. 1988 Clin. Chim. Acta pmid:3359655
Hsueh W et al. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor. A mechanistic study of platelet-activating factor-induced bowel necrosis. 1988 Gastroenterology pmid:3360262
Breviario F et al. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. 1988 J. Immunol. pmid:3263425
Page CP The role of platelet-activating factor in asthma. 1988 J. Allergy Clin. Immunol. pmid:3276759
Barnes PJ Platelet-activating factor and asthma. 1988 J. Allergy Clin. Immunol. pmid:3276760
Royall JA and Levin DL Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. 1988 J. Pediatr. pmid:3276861
Vanhoutte PM Platelets, endothelium and blood vessel wall. 1988 Experientia pmid:3278917
Rubin RM and Rosenbaum JT A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation. 1988 Biochem. Biophys. Res. Commun. pmid:3260779
Dillon PK et al. Effect of platelet-activating factor on leukocyte adhesion to microvascular endothelium. Time course and dose-response relationships. 1988 Inflammation pmid:3220518
Lohmann HF et al. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086. 1988 Lancet pmid:2903365
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520
Lakin KM et al. [Action of calcium antagonists on thrombocyte aggregation]. 1987 Sep-Oct Farmakol Toksikol pmid:2826225
Berdel WE et al. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro. 1987 Nov-Dec Anticancer Res. pmid:3442414
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Arnoux B et al. Antigenic release of paf-acether and beta-glucuronidase from alveolar macrophages of asthmatics. 1987 Mar-Apr Bull Eur Physiopathol Respir pmid:3607326
Lurie A et al. Exercise- and allergen-induced asthma do not change the production of Paf-acether by neutrophils and platelets. 1987 Jul-Aug Bull Eur Physiopathol Respir pmid:3690021
Auriault C et al. The effector function of platelets is induced and regulated by T lymphocytes. 1987 Jul-Aug Ann. Inst. Pasteur Immunol. pmid:3118905
Liu BN [Neoplastic membrane-toxic activity as one of the pathogenetic factors in blood cell and tumor growth changes]. 1987 Jan-Feb Patol Fiziol Eksp Ter pmid:3550649
Joly F et al. Ketotifen inhibits paf-acether biosynthesis and beta-hexosaminidase release in mouse mast cells stimulated with antigen. 1987 Eur. J. Pharmacol. pmid:2963750
Bussolino F et al. Chick retina generates platelet-activating factor. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2890284
Mikashima H et al. An antagonistic activity of etizolam on platelet-activating factor (PAF). In vitro effects on platelet aggregation and PAF receptor binding. 1987 Jpn. J. Pharmacol. pmid:2890779
Gautheron PD et al. A study of PAF-induced ocular inflammation in the rat and its inhibition by the PAF antagonist, L-652,731. 1987 J. Pharm. Pharmacol. pmid:2891830
Kornecki E et al. Interactions of the alkyl-ether-phospholipid, platelet activating factor (PAF) with platelets, neural cells, and the psychotropic drugs triazolobenzodiazepines. 1987 Adv. Exp. Med. Biol. pmid:2893525
Rylander R and Beijer L Inhalation of endotoxin stimulates alveolar macrophage production of platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3541718
Dejana E et al. Modulation of endothelial cell functions by different molecular species of interleukin 1. 1987 Blood pmid:3542082
Lucchesi BR et al. Interaction of the formed elements of blood with the coronary vasculature in vivo. 1987 Fed. Proc. pmid:3542578
Stafforini DM et al. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. 1987 J. Biol. Chem. pmid:3549727
Christman BW et al. Effect of platelet-activating factor on aerosol histamine responsiveness in awake sheep. 1987 Am. Rev. Respir. Dis. pmid:3592402
Benveniste J A role for paf-acether (platelet-activating factor) in bronchial hyperreactivity? 1987 Am. Rev. Respir. Dis. pmid:3592414
Tokumura A et al. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain. 1987 Biochem. Biophys. Res. Commun. pmid:3593346
Kojima S et al. Cooperativity between platelet-activating factor and collagen in platelet aggregation. 1987 Biochem. Biophys. Res. Commun. pmid:3593379
Stenmark KR et al. Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. 1987 Am. Rev. Respir. Dis. pmid:3631747
O'Donnell SR and Barnett CJ Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi. 1987 Eur. J. Pharmacol. pmid:3040440
Okayasu T et al. Platelet-activating factor stimulates metabolism of phosphoinositides via phospholipase A2 in primary cultured rat hepatocytes. 1987 J. Lipid Res. pmid:3040878
Deguchi K et al. [Platelet activating factor]. 1987 Nippon Rinsho pmid:3041069
Neuwirth R et al. Effect of platelet activating factor antagonists on cultured rat mesangial cells. 1987 J. Pharmacol. Exp. Ther. pmid:3119816
Fennessy MR et al. Lipid mediators of anaphylaxis and increased airways reactivity. 1987 Clin. Exp. Pharmacol. Physiol. pmid:2824102
Nakamura T et al. Platelet-activating factor in late asthmatic response. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3804454
Wallace JL et al. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. 1987 Gastroenterology pmid:3305134
Barnes PJ The changing face of asthma. 1987 Q. J. Med. pmid:3310071
Schellenberg RR Airway responses to platelet-activating factor. 1987 Am. Rev. Respir. Dis. pmid:3310779
O'Neill C Embryo-derived platelet activating factor: a preimplantation embryo mediator of maternal recognition of pregnancy. 1987 Domest. Anim. Endocrinol. pmid:3333935
Chabot MC et al. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. 1987 Biochim. Biophys. Acta pmid:2823907
Camussi G et al. Release of platelet-activating factor from rabbit heart perfused in vitro by sera with transplantation alloantibodies. 1987 Transplantation pmid:3299910
Zimmerman GA et al. Production of platelet-activating factor, a biologically active lipid, by vascular endothelial cells. 1987 Am. Rev. Respir. Dis. pmid:3300444
Murphy RC and Clay KL Measurement of platelet-activating factor by physicochemical technique s. 1987 Am. Rev. Respir. Dis. pmid:3300445
Braquet P et al. Perspectives in platelet-activating factor research. 1987 Pharmacol. Rev. pmid:3303066
Chen DC [Phosphoinositide metabolism and platelet activation]. 1987 Sheng Li Ke Xue Jin Zhan pmid:2838899
Sudan BJ Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis. 1987 Med. Hypotheses pmid:2886895
Ostermann G et al. Modification of the polar head group of platelet-activating factor: influence on the biological activity. 1987 Chem. Phys. Lipids pmid:3607969
Hwang SB Specific receptor sites for platelet activating factor on rat liver plasma membranes. 1987 Arch. Biochem. Biophys. pmid:2821908
Robaut C et al. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets. 1987 Biochem. Pharmacol. pmid:2822048
Leff AR et al. Parasympathetic involvement in PAF-induced contraction in canine trachealis in vivo. 1987 J. Appl. Physiol. pmid:2881917
McIntyre TM et al. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. 1987 J. Biol. Chem. pmid:2824456
Khandwala A et al. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release. 1987 Biochem. Pharmacol. pmid:2435293
Hartiala KT et al. Lack of correlation between calcium mobilization and respiratory burst activation induced by chemotactic factors in rabbit polymorphonuclear leukocytes. 1987 Biochem. Biophys. Res. Commun. pmid:3034265
Alloatti G et al. Protective effect of verapamil on the cardiac and circulatory alterations induced by platelet-activating factor. 1987 J. Cardiovasc. Pharmacol. pmid:2435996
Kappa JR et al. Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374). 1987 J. Vasc. Surg. pmid:2437338
de Arriba G et al. Changes in glomerular cross-sectional area induced by platelet activating factor. 1987 Nephrol. Dial. Transplant. pmid:3118261
Morley J and Sanjar S PAF, ketotifen and asthma. 1987 N. Z. Med. J. pmid:3468405
Darius H and Lefer AM Pharmacologic antagonism of platelet activating factor and peptide leukotrienes inhibits guinea pig anaphylaxis. 1987 Prog. Clin. Biol. Res. pmid:3118384
Shalit M et al. Platelet-activating factor both stimulates and "primes" human polymorphonuclear leukocyte actin filament assembly. 1987 Blood pmid:3118991
Sweatt JD et al. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. 1987 Circ. Res. pmid:2822286